CYBERDYNE Inc.

Equities

7779

JP3311530004

Healthcare Facilities & Services

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
203 JPY -2.40% Intraday chart for CYBERDYNE Inc. +6.28% -9.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization CI
Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings MT
Cyberdyne to Sign a Consignment Agreement with NEDO; Expects 332 Million Yen in Other Income for Fiscal 2023 MT
Cyeberdyne Appoints Shinji Honda as New Executive Director and COO MT
CYBERDYNE Inc. Appoints Shinji Honda as New Executive Director and Chief Operating Officer, Effective December 18, 2023 CI
Cyberdyne Books 660 million Yen in Impairment Loss in Fiscal Q2 MT
Cyberdyne Secures Grant for Development of Robotic Care Device Overseas MT
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 1-JUN-2023. CI
CYBERDYNE Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
CYBERDYNE Inc. completed the acquisition of 8% stake in LeyLine GmbH from Midori Moriwaki. CI
Cyberdyne to Take Controlling Stake in German Racing Team Operator MT
CYBERDYNE Inc. signed an agreement to acquire 8% stake in LeyLine GmbH from Midori Moriwaki. CI
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 28-FEB-2023. CI
Cyberdyne Repurchases 1.2 Billion Yen Worth of Stock; Shares Gain 4% MT
Tranche Update on CYBERDYNE Inc.'s Equity Buyback Plan announced on February 20, 2023. CI
CYBERDYNE Inc.'s Equity Buyback announced on February 20, 2023, has closed with 4,000,000 shares, representing 1.86% for ¥1,188 million. CI
CYBERDYNE Inc. announces an Equity Buyback for 4,000,000 shares, representing 2.91% for ¥1,188 million. CI
CYBERDYNE Inc. authorizes a Buyback Plan. CI
Cyberdyne Inc. Announces Yuzo Toda Passed Away on December 27, 2022, and Retired from the Position of Director on the Same Day CI
Cyfuse Biomedical K.K. has completed an IPO in the amount of Ñ2.477466 billion. CI
Cyfuse Biomedical K.K. has filed an IPO. CI
Hirosaki Lifescience Innovation, Inc. announced that it has received funding from CYBERDYNE Inc. CI
Xenoma, Inc. announced that it has received funding from CYBERDYNE Inc. CI
Metcela Inc. announced that it has received ¥1.87 billion in funding from CYBERDYNE Inc., CEJ Capital Co., Ltd., Japan Lifeline Co., Ltd., Sony Ventures Corporation, Reazon Holdings, Inc. CI
Cyberdyne to Set Up Malaysian Subsidiary MT
Chart CYBERDYNE Inc.
More charts
Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
203 JPY
Average target price
320 JPY
Spread / Average Target
+57.64%
Consensus
  1. Stock Market
  2. Equities
  3. 7779 Stock
  4. News CYBERDYNE Inc.
  5. Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings